in view of the pharmacokinetic profile of imipenem/cilastatin , the microbiologic activity of imipenem , and the post-antibiotic effect of imipenem against pseudomonas aeruginosa , imipenem/cilastatin has the potential to control the majority of bacteremic nosocomial pathogens .
C0020933
imipenem
C0071972
imipenem/cilastatin